Here we present a microRNA (miRNA) knockdown application, based on the use of Locked Nucleic Acid (LNA™)-modified probes. The use of LNA for the knockdown of miRNA is particularly effective ...

(NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced the publication of preclinical data ...

This article highlights the current state of macromolecular gene delivery systems, their applications, and the ongoing ...

A team of NYU chemists and physicists are using cutting-edge tools—holographic microscopy and super-resolution imaging—to ...

The Wacker Biotechnology Center is in Munich, where the company has been conducting fundamental research for over a century.

Gene therapy has emerged as a revolutionary approach to treating genetic disorders by directly addressing underlying genetic abnormalities. However ...

CRISPR-based gene editing holds great promise, but off-target effects remain a major concern, especially across diverse ...

Wacker Chemie A.G. has opened an expanded, "double-digit millions of dollars" facility for biotechnology research in food and ...

Imagine if you could "print" a tiny skyscraper using DNA instead of steel. That’s what researchers at Columbia and Brookhaven ...

The variety of potentially useful dyes or haptenes available for fluorescent nucleic acid hybridization assays is far greater than what can be obtained from commercial sources 1,2. Since this ...

A team of NYU chemists and physicists are using cutting-edge tools—holographic microscopy and super-resolution imaging—to ...

When the Empire State Building was constructed, its 102 stories rose above midtown one piece at a time, with each individual element combining to become, for 40 years, the world's tallest building.